Biotech Updates

Bryotechnology Collaboration of Sartorius Stedim Biotech and greenovation Biotech GmbH

October 31, 2007

Sartorius Stedim Biotech (experts of fermentation and purification process engineering) and greeninovation Biotech (developer of the proprietary bryotechnology) have successfully collaborated and developed a fermentation process using bryotechnology (moss technology). Specific genetic modifications of the moss cells allow scientists to develop desired therapeutic protein according to a predefined building plan. By further genetically modifying the moss cells, the proteins are refined to enhance their performance through glycoengineering that involves attachment of  the plant-specific sugar molecule to meet the customer's specifications. 

The announced new collaboration will be a scale-up project implementation of the plant-based bryotechnology. This technology makes simplifies the process engineering involved in drug manufacturing. Moss cells are very easy to work with, requiring simple culture medium composition which eventually result in significant reduction in investment costs and ultimately, in more affordable pharmaceutical medicines.

 For details, see press release at: http://www.sartorius-stedim.com/index.php?id=5710&tx_ttnews[tt_news]=5642&tx_ttnews[backPid]=5709&cHash=9d78ca3262